Whole body FDG PET-CT is an important adjunct to conventional morphologic imaging in evaluating suspected malignant transformation in osteochondromas. Increased glucose metabolism can help diagnose sarcomatous transformation at the suspected sites as well as detect early malignant change at clinically unsuspected sites. Moreover, its ability to detect a focus of dedifferentiation can be useful for prognostication and to plan adjuvant treatment. A small cohort limits statistically sound conclusions to be drawn from this study, however further prospective trials based on these findings can help explore the potential application of FDG PET-CT in this clinical condition.
Background: Whole-body computed tomography (WBCT) is used indiscriminately in trauma cases, just on the suspicion of them being polytrauma cases. A good clinical examination done pre-emptively could prevent the need for this investigation and its undesirous effects. We did this study with an overall aim to assess, if WBCT can be limited to subgroup of trauma patients without compromising clinical safety. Methods: Retrospective database analysis of 150 cases of polytrauma who underwent WBCT in 2017 was performed. We recorded age, gender, radiation dose and CT findings in all cases and calculated mean age, number of total patients and female patients less than 25 years of age, number of normal WBCT scans, mean radiation dose in the normal and total scans. We also compared pre-test clinical requests with whole-body CT findings, and categorised them in following seven categories: Category 1-Normal Scans; Category 2-Clinically expected Major Injuries; Category 3-Clinically expected Minor Injuries (low risk injuries with no risk of morbidity or mortality if remained undiagnosed), Category 4-Clinically expected CT findings with unexpected Minor (non-serious) injuries; Category 5-Clinically expected CT findings with unexpected Major (serious) injuries, Category 6-Unexpected Minor (non-serious) injuries; Category 7-Unexpected Major (serious) injuries. Categories 2 &3 of clinically expected major and minor injuries included patients with fewer injuries than expected. On the other hand, Category 4 & 5 consist of clinically expected findings with other unexpected injuries, including minor and major injuries respectively. Body injuries were reported in seven areas as per our institutional reporting protocol-Head (including face), Cervical Spine, Thoracolumbar Spine, Chest, Abdomen, Pelvis and Appendicular Skeleton (if asked for). Results: Overall, we found statistically significant correlation between clinical suspicion raised and WBCT findings with good clinical correlation noticed in 106 (70.66%) cases (including 61 cases of clinically suspected major injuries, 15 cases of clinically suspected minor injuries and 25 nearly normal scans with no obvious clinical concern). Isolated unexpected serious injury without any clinical suspicion was seen in only 1 case. Surprisingly, 25 scan requests were made due to high risk mechanism of injury with no obvious clinical concern and were found normal in 20 cases and showed very subtle injuries in 5. Notably, 30 cases of expected major and minor injuries showed highly accurate clinical findings with no injury other than the region of concern and in these cases, limited scan requests would have been sufficient. Mean radiation dose of the entire study group was 22.45 mSv and those to normal patients was 21.19 mSv. Conclusions: This study re-emphasizes the significance of good clinical examination in the era of evidence based medicine, which would reduce the high number of unnecessary high dose WBCT (25 scans with no positive findings on clinical examination were nearly normal and in 30 ca...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.